Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients

B. Coevoet, C. Desplan, J. L. Sebert, R. Makdassi, M. Andrejak, J. D. Gheerbrant, M. Tolani, C. Calmette, M. S. Moukhtar, A. Fournier

Research output: Contribution to journalArticle

Abstract

9 uraemic patients not being treated by dialysis received intravenous propranolol 1 μg/kg/min for 85 min. after a priming dose of 1 mg. 15 days later, 6 of them received intravenous metoprolol 1.2 μg/kg/min after a priming dose of 1.2 mg. Plasma concentrations of parathyroid hormone (PTH) and calcitonin fell significantly after propranolol but not after metoprolol, whereas no change in plasma concentrations of ionised calcium and phosphate occurred with either drug. Heart rate fell similarly with both drugs. The fact that propranolol acutely suppressed PTH and calcitonin secretion in uraemic patients indicates that further studies are warranted to assess the long-term effects of the drug on the secretion of these hormones and on renal osteodystrophy. The contrast between the responses to propranolol and metoprolol supports the concept that PTH and calcitonin secretion is modulated through specific beta 2-receptors.

Original languageEnglish (US)
Pages (from-to)1344-1346
Number of pages3
JournalBritish Medical Journal
Volume280
Issue number6228
StatePublished - 1980

Fingerprint

Metoprolol
Calcitonin
Parathyroid Hormone
Propranolol
Pharmaceutical Preparations
Chronic Kidney Disease-Mineral and Bone Disorder
Dialysis
Heart Rate
Hormones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Coevoet, B., Desplan, C., Sebert, J. L., Makdassi, R., Andrejak, M., Gheerbrant, J. D., ... Fournier, A. (1980). Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients. British Medical Journal, 280(6228), 1344-1346.

Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients. / Coevoet, B.; Desplan, C.; Sebert, J. L.; Makdassi, R.; Andrejak, M.; Gheerbrant, J. D.; Tolani, M.; Calmette, C.; Moukhtar, M. S.; Fournier, A.

In: British Medical Journal, Vol. 280, No. 6228, 1980, p. 1344-1346.

Research output: Contribution to journalArticle

Coevoet, B, Desplan, C, Sebert, JL, Makdassi, R, Andrejak, M, Gheerbrant, JD, Tolani, M, Calmette, C, Moukhtar, MS & Fournier, A 1980, 'Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients', British Medical Journal, vol. 280, no. 6228, pp. 1344-1346.
Coevoet B, Desplan C, Sebert JL, Makdassi R, Andrejak M, Gheerbrant JD et al. Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients. British Medical Journal. 1980;280(6228):1344-1346.
Coevoet, B. ; Desplan, C. ; Sebert, J. L. ; Makdassi, R. ; Andrejak, M. ; Gheerbrant, J. D. ; Tolani, M. ; Calmette, C. ; Moukhtar, M. S. ; Fournier, A. / Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients. In: British Medical Journal. 1980 ; Vol. 280, No. 6228. pp. 1344-1346.
@article{c115e0032cfd441b8cc679ff87b1218a,
title = "Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients",
abstract = "9 uraemic patients not being treated by dialysis received intravenous propranolol 1 μg/kg/min for 85 min. after a priming dose of 1 mg. 15 days later, 6 of them received intravenous metoprolol 1.2 μg/kg/min after a priming dose of 1.2 mg. Plasma concentrations of parathyroid hormone (PTH) and calcitonin fell significantly after propranolol but not after metoprolol, whereas no change in plasma concentrations of ionised calcium and phosphate occurred with either drug. Heart rate fell similarly with both drugs. The fact that propranolol acutely suppressed PTH and calcitonin secretion in uraemic patients indicates that further studies are warranted to assess the long-term effects of the drug on the secretion of these hormones and on renal osteodystrophy. The contrast between the responses to propranolol and metoprolol supports the concept that PTH and calcitonin secretion is modulated through specific beta 2-receptors.",
author = "B. Coevoet and C. Desplan and Sebert, {J. L.} and R. Makdassi and M. Andrejak and Gheerbrant, {J. D.} and M. Tolani and C. Calmette and Moukhtar, {M. S.} and A. Fournier",
year = "1980",
language = "English (US)",
volume = "280",
pages = "1344--1346",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "6228",

}

TY - JOUR

T1 - Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients

AU - Coevoet, B.

AU - Desplan, C.

AU - Sebert, J. L.

AU - Makdassi, R.

AU - Andrejak, M.

AU - Gheerbrant, J. D.

AU - Tolani, M.

AU - Calmette, C.

AU - Moukhtar, M. S.

AU - Fournier, A.

PY - 1980

Y1 - 1980

N2 - 9 uraemic patients not being treated by dialysis received intravenous propranolol 1 μg/kg/min for 85 min. after a priming dose of 1 mg. 15 days later, 6 of them received intravenous metoprolol 1.2 μg/kg/min after a priming dose of 1.2 mg. Plasma concentrations of parathyroid hormone (PTH) and calcitonin fell significantly after propranolol but not after metoprolol, whereas no change in plasma concentrations of ionised calcium and phosphate occurred with either drug. Heart rate fell similarly with both drugs. The fact that propranolol acutely suppressed PTH and calcitonin secretion in uraemic patients indicates that further studies are warranted to assess the long-term effects of the drug on the secretion of these hormones and on renal osteodystrophy. The contrast between the responses to propranolol and metoprolol supports the concept that PTH and calcitonin secretion is modulated through specific beta 2-receptors.

AB - 9 uraemic patients not being treated by dialysis received intravenous propranolol 1 μg/kg/min for 85 min. after a priming dose of 1 mg. 15 days later, 6 of them received intravenous metoprolol 1.2 μg/kg/min after a priming dose of 1.2 mg. Plasma concentrations of parathyroid hormone (PTH) and calcitonin fell significantly after propranolol but not after metoprolol, whereas no change in plasma concentrations of ionised calcium and phosphate occurred with either drug. Heart rate fell similarly with both drugs. The fact that propranolol acutely suppressed PTH and calcitonin secretion in uraemic patients indicates that further studies are warranted to assess the long-term effects of the drug on the secretion of these hormones and on renal osteodystrophy. The contrast between the responses to propranolol and metoprolol supports the concept that PTH and calcitonin secretion is modulated through specific beta 2-receptors.

UR - http://www.scopus.com/inward/record.url?scp=0018860458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018860458&partnerID=8YFLogxK

M3 - Article

VL - 280

SP - 1344

EP - 1346

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

IS - 6228

ER -